Brian Armstrong Will Sell 2% Of His Coinbase Holdings To Fund Scientific Research
October 15 2022 - 4:12AM
NEWSBTC
It’s time for Brian Armstrong to make his move. While other
billionaire CEOs try to buy bankrupt crypto companies on the cheap,
the Coinbase leader is focusing his sights on hard science. To
announce his new endeavors Brian Armstrong visited Tim Ferriss’
podcast. In that interview, he expanded on the deep topics that the
companies he’ll fund deal with. Make no mistake, though. The real
announcement was that Brian Armstrong is selling Coinbase stock.
I’m sharing this as I want you to hear it from me first. — Brian
Armstrong (@brian_armstrong) October 15, 2022 In a recent Twitter
thread, the Coinbase CEO wrote, “I’m passionate about accelerating
science and tech to help solve some of the biggest challenges in
the world. To further this, I’m planning to sell about 2% of my
Coinbase holdings over the next year to fund scientific research
and companies like NewLimit + ResearchHub.” What are those
companies and what do they do? Keep reading to find out. Related
Reading: Brian Armstrong Says Crypto Can Beat Inflation, What Does
The Chart Suggest? Considering the alarming amount of crypto CEOs
leaving their positions, it’s important that Brian Armstrong
cleared this up. “For the avoidance of doubt, I intend to be CEO of
Coinbase for a very long time and I remain super bullish on crypto
and Coinbase. I’m fully dedicated to growing our business and
advancing our mission, but I am also excited to contribute in a
different way,” he tweeted. What are the ideas that excite Brian
Armstrong this much? Let’s find out. Brian Armstrong ’s ResearchHub
And NewLimit So, Brian Armstrong will “fund scientific research and
companies like NewLimit + ResearchHub.” What do those companies
stand for, though? Well, ResearchHub is “a tool for the open
publication and discussion of scientific research. Researchhub’s
users are rewarded with ResearchCoin (RSC) for publishing,
reviewing, criticizing, and collaborating in the open.”
Interesting, an open scientific think tank with a cryptocurrency
component. For its part, ResearchCoin is both a utility token and a
governance token. “RSC gives users the ability to create bounties,
tip other users, and gain voting rights within community decision
making.” This is the project’s Twitter account. On the other hand,
NewLimit is “treating age-related disease to extend human
healthspan” and “developing epigenetic reprogramming medicines to
treat diseases with large unmet needs.” This is their Twitter
account. This one is in the life extension business, but the
specifics are harder to grasp. Luckily, NewLimit offers a blog post
authored by Brian Armstrong himself in which he goes deep into the
topic at hand: “NewLimit will start by deeply interrogating
epigenetic drivers of aging and developing products that can
regenerate tissues to treat specific patient populations. We will
start by using primary human cells and reference species to develop
machine learning models on what chromatin features change with age,
which of these changes may be causal to the aging process, and
finally develop therapies that could slow, halt, or reverse this
process.” In that same blog post, we learn that the company was
“co-founded by Brian Armstrong and Blake Byers with the mission of
extending human healthspan.” And thus, we figure out that Coinbase
CEO is the money behind both companies. The relationship between
COIN and USDT on Bittrex | Source: COIN/USDT on TradingView.com The
Tim Ferriss Interview To launch his new endeavors in the right way,
Brian Armstrong went to the popular Tim Ferriss podcast. In it, he
presented the reasoning behind his investments. “I think we’re kind
of in this golden age of software where fortunes are being made.
But some of that wealth, even in crypto, is now being directed into
hard science, hard science problems, atoms, not bits,” he said. As
to what the company actually does, Armstrong explained that they’re
trying to “build a platform that tests a lot of different
transcription factors with different cell types and uses machine
learning to do that in a virtuous cycle.” He also explained the
entrepreneurial spirit behind the whole ordeal. “We’re trying to
help humans live much longer, not just a little bit longer. But I
think in any good moonshot company, you want to have intermediate
milestones along the way. And so the intermediate milestones are
more like, could we get a specific type of cell to be rejuvenated
and be younger?” Thanks to @tferris who I recently spoke with about
these interests: https://t.co/0EUdzICfVV — Brian Armstrong
(@brian_armstrong) October 15, 2022 About ResearchHub, the Coinbase
CEO confirmed that it is “another company that I funded and tried
to help get off the ground.” What does this one do? “We’re
trying to make it easy for people to sort through all of the
millions of papers that are published every year to what are the
most impactful. We’re trying to help get things like peer review,
Q&A, comments, feedback around research to be more
collaborative with people.” Related Reading: How Brian Armstrong,
CEO of Coinbase, Became a Crypto Billionaire And those are the
ideas that Brian Armstrong will dedicate the next part of his life
to. While at the same time serving as Coinbase’s CEO, of course.
Featured Image: Screenshot from this video | Charts by TradingView
EOS (COIN:EOSUSD)
Historical Stock Chart
From Jun 2024 to Jul 2024
EOS (COIN:EOSUSD)
Historical Stock Chart
From Jul 2023 to Jul 2024